36997569

Summary
Title
Results of a phase Ib study of SB-121, an investigational probiotic formulation, a randomized controlled trial in participants with autism spectrum disorder.
Authors
  • Schmitt LM
  • Smith EG
  • Pedapati EV
  • Horn PS
  • Will M
  • Lamy M
  • Barber L
  • Trebley J
  • Meyer K
  • Heiman M
  • West KHJ
  • Hughes P
  • Ahuja S
  • Erickson CA
Source
Sci Rep
Publication Date
2023 Mar 30
PubMed ID
36997569

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024